Pick a Topic:
Find info on a:
ClotCare complies with the HONcode standard for trustworthy health
ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.
Poor adherence as a potential source of poor anticoagulation control
Seikeng Koh, M.Pharm*, Edith A. Nutescu, Pharm D
Reference: Kimmel SE, Chen Z, Price M, Parker CS, Metlay JP,Christic JD et al. The influence of patient adherence on anticoagulation control with warfarin: results from the international normalized ratio adherence and genetics (IN-RANGE) study. Arch Intern Med 2007; 167: 229-235.
Patients with poor adherence to their warfarin therapy have poor anticoagulation control even if they are being managed in specialized anticoagulation clinics.
The international normalized ratio adherence and genetics (IN-RANGE) study was a prospective cohort study of 136 patients conducted in 3 anticoagulation clinics and over a period of 32 weeks looking into the impact of warfarin adherence and genetic variability on anticoagulation control. This first report (reviewed here) looked into the adherence factor affecting anticoagulation control. The medication event monitoring system (MEMS) was used to track timing of medication use. The number of incorrect warfarin dose days, over adherent and under adherent days and INR at each visit were calculated. A total of 1490 INR measurements were taken; 40.4% of them were out of range with 25.8% below and 14.6% above the target range. Under anticoagulation was more likely associated with patients who refused to use the MEMS caps (p=0.006) and were noncompliant to their warfarin therapy (p<0.001). Missing 1 to 2 doses a week (20%-30% missed doses) was associated with up to a 2-fold increased odds of sub therapeutic anticoagulation. Over adherence was associated with over-anticoagulation but not under anticoagulation. Neither the phase of therapy (initiation vs maintenance, p>0.5) nor the length of interval between visits (p>0.10) had an impact on the INR-adherence associations. The authors concluded that poor adherence was a potential course of poor anticoagulation control even if the patients were managed by anticoagulation clinics where the importance of adherence was constantly emphasized.
*Seikeng Koh is a pharmacist with the Singapore General Hospital who is currently doing an anticoagulation rotation with Dr. Edith Nutescu at the Antithrombosis Unit, UIC.
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2014 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-495-4335
Send comments to email@example.com.
Friday, March 24, 2017